Protein Misfolding Disease

Alzheimer's disease, a progressive neurodegenerative condition, is distinguished by the misfolding and aggregation of proteins within the brain. Beta-amyloid plaques and tau tangles are the main offenders, disrupting neuronal communication and triggering symptoms such as memory loss, cognitive decline, and behavioral changes. This accumulation of abnormal proteins progressively impairs brain function, marking Alzheimer's as the most prevalent form of dementia globally. The disease presents formidable challenges for healthcare systems and families alike. Ongoing research is focused on unraveling the mechanisms behind protein misfolding, identifying early biomarkers, and developing novel therapies to either slow down or stop its advancement. Effective treatments remain elusive, underscoring the intricate nature of protein misfolding diseases and emphasizing the critical need for innovative approaches in diagnosis and treatment.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jun Hua

Jun Hua

Johns Hopkins University , United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Nazneen N Dewji

Nazneen N Dewji

Cenna Biosciences Inc, United States
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline London

Jacqueline London

Paris Diderot University, France
Tags

Submit your abstract Today

Whatsapp